NASDAQ: LBPH - Longboard Pharmaceuticals, Inc.

Доходность за полгода: +238.76%
Сектор: Healthcare

График акции Longboard Pharmaceuticals, Inc.

Расширенный график Простой график
Financial Markets by TradingView

О компании

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. Its lead product candidate is LP352, which is in Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. The company's preclinical product candidate includes LP659 which focuses on developing therapies for multiple neurological diseases; and LP143. It also entered into license agreement with Arena Pharmaceuticals Inc.

Подробнее
to develop and commercialize LP352, LP659, LP143, and other compounds. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.
Добавить в список сравнения
Добавить в список отслеживания
Добавить в портфель
Добавить уведомление о цене

Цена ао 58.86
EBITDA -0.0144
Число акций ао 0.02273 млрд
P/BV 0.8062
EV/EBITDA 3.84
ISIN US54300N1037
Сайт https://www.longboardpharma.com
Валюта usd
IPO date 2021-03-12
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Изменение цены за день: 0% (59.08)
Изменение цены за неделю: +77.1% (33.36)
Изменение цены за месяц: +72.14% (34.32)
Изменение цены за 3 месяца: +64.11% (36)
Изменение цены за полгода: +238.76% (17.44)
Изменение цены за год: +1 115.64% (4.86)
Изменение цены за 3 года: +551.38% (9.07)
Изменение цены с начала года: +1 154.35% (4.71)
Все параметры

Недооценка

Название Значение Оценка
P/S 0 0
P/BV 3.44 5
P/E 0 0
EV/EBITDA -2.24 0
Итого: 3.13

Эффективность

Название Значение Оценка
ROA, % -107.35 0
ROE, % -132.99 0
Итого: 0

Дивиденды

Название Значение Оценка
Div yield, % 0 0
DSI 0 0
Итого: 0

Долг

Название Значение Оценка
Debt/EBITDA -0.0084 10
Итого: 8

Импульс роста

Название Значение Оценка
Доходность Revenue, % 0 0
Доходность Ebitda, % 294.13 10
Доходность EPS, % 181.33 10
Итого: 8
Подробнее

Институционалы Объем Доля, %
Cormorant Asset Management, LP 2353141 7
FMR, LLC 1649503 4.91
Price (T.Rowe) Associates Inc 1626982 4.84
Farallon Capital Management Llc 1560500 4.64
Polar Capital Holdings PLC 1000000 2.98
Ikarian Capital, LLC 979462 2.91
Integral Health Asset Management, LLC 900000 2.68
Blackrock Inc. 869879 2.59
Point72 Asset Management, L.P. 825000 2.45
Vanguard Group Inc 786433 2.34

ETF Доля, % Доходность за год, % Дивиденды, %
Avantis U.S Small Cap Equity ETF 0.01814 29.82202982203 1.68271
Avantis U.S. Equity ETF 0.00066 33.70907064233 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 1.3448 70.704717530577 0.33
iShares ESG Aware MSCI USA Small-Cap ETF 0.04743 30.96062992126 1.49366
Fidelity MSCI Health Care Index ETF 0.01532 18.888144675151 1.46057
ProShares Hedge Replication ETF 0.0058 5.5087969920031 1.47892
Humankind US Stock ETF 0.00353 19.097374981669 1.99919
iShares Neuroscience and Healthcare ETF 2.11526 21.135856403438 0.03
iShares Morningstar Small-Cap ETF 0.01851 33.791994568546 1.60498
iShares Morningstar Small-Cap Growth ETF 0.01676 36.150627615063 0.72598
iShares Morningstar Small Cap Value ETF 0.02069 31.139293139293 2.50476
iShares Micro-Cap ETF 0.27803 35.054312164247 1.54048
iShares Russell 2000 Growth ETF 0.08101 34.028337203241 0.6026
iShares Russell 3000 ETF 0.00126 36.935557303092 1.43482
iShares Morningstar Small-Cap ETF 0.01851 394.56115994361 1.60498
iShares Morningstar Small-Cap Growth ETF 0.01676 739.4866193337 0.72598
iShares Morningstar Small-Cap Value ETF 0.02069 240.07875566056 2.50476
Nuveen ESG Small-Cap ETF 0.09807 29.699017199017 1.41019
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 1.2465 61.576086956522 1.2989
ProShares UltraPro Russell2000 0.02367 81.385281385281 1.47873
Vanguard U.S. Momentum Factor ETF 0.18 52.658902764136 1.05834
Vanguard Russell 3000 ETF 0 35.867021276596 1.43817
Vanguard Russell 2000 Growth ETF 0.09 34.809548656405 0.60264
Vanguard Russell 2000 ETF 0.04 32.304263853811 1.48801
SPDR S&P Pharmaceuticals ETF 2.34795 25.783592259471 1.29889



Руководитель Должность Оплата Год рождения
Mr. Kevin R. Lind President, CEO, Secretary & Director 1.07M 1976 (48 лет)
Ms. Brandi L. Roberts CPA, M.B.A. Executive VP & CFO 662.65k 1974 (50 лет)
Dr. Randall E. Kaye M.D. Executive VP & Chief Medical Officer 717.95k 1962 (62 года)
Mr. Chadwick J. Orevillo MPH Executive VP & Head of Operations N/A
Mr. Steven W. Spector J.D. Executive VP, Head of Business Development & General Counsel N/A 1965 (59 лет)
Dr. Anne M. Danks Ph.D. VP & Head of Nonclinical Research & Development N/A
Mr. Gus Cardenas VP & Head of Quality Assurance N/A
Dr. Marco Peters Ph.D. VP & Head of Translational Science N/A
Dr. Dewey McLin Ph.D. VP & Head of Medical Affairs N/A
Ms. Megan E. Knight VP & Head of Investor Relations

Адрес: United States, La Jolla. CA, 4275 Executive Square - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.longboardpharma.com